Yiyang C. Wang

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Targeted drug delivery systems for cardiovascular disease treatment: principles, targeting strategies, and future prospects.

Targeted drug delivery systems for cardiovascular disease treatment: principles, targeting strategies, and future prospects.

Journal: Annals of medicine

Published: May 11, 2026

Engineering an orthogonal ubiquitin transfer cascade with RING E3 RNF38 by phage display to reveal its regulation of nuclear transport.

Engineering an orthogonal ubiquitin transfer cascade with RING E3 RNF38 by phage display to reveal its regulation of nuclear transport.

Journal: The Journal of biological chemistry

Published: July 19, 2025

Effectiveness evaluation of standardized patient training system on emergency department residents in disposing patients with acute chest pain.

Effectiveness evaluation of standardized patient training system on emergency department residents in disposing patients with acute chest pain.

Journal: BMC medical education

Published: June 19, 2025

E3 ligase CHIP restoration facilitates the effect of α1-adrenoceptor blockage on alleviating lipopolysaccharide-caused cardiac fibrosis via downregulating TGF-BR1 expression and Smad2/3 activation.

E3 ligase CHIP restoration facilitates the effect of α1-adrenoceptor blockage on alleviating lipopolysaccharide-caused cardiac fibrosis via downregulating TGF-BR1 expression and Smad2/3 activation.

Journal: Molecular biomedicine

Published: May 27, 2025

Dexmedetomidine therapy promotes cardiac dysfunction and increases mortality in sepsis: A translational study.

Dexmedetomidine therapy promotes cardiac dysfunction and increases mortality in sepsis: A translational study.

Journal: International immunopharmacology

Published: October 22, 2024

ENDOGENOUS β 3 -ADRENERGIC RECEPTOR ACTIVATION ALLEVIATES SEPSIS-INDUCED CARDIOMYOCYTE APOPTOSIS VIA PI3K/AKT SIGNALING PATHWAY.

ENDOGENOUS β 3 -ADRENERGIC RECEPTOR ACTIVATION ALLEVIATES SEPSIS-INDUCED CARDIOMYOCYTE APOPTOSIS VIA PI3K/AKT SIGNALING PATHWAY.

Journal: Shock (Augusta, Ga.)

Published: April 25, 2024

Endothelial α1-adrenergic receptor activation improves cardiac function in septic mice via PKC-ERK/p38MAPK signaling pathway.

Endothelial α1-adrenergic receptor activation improves cardiac function in septic mice via PKC-ERK/p38MAPK signaling pathway.

Journal: International immunopharmacology

Published: April 22, 2024

Geranylgeranylacetone mitigates sepsis-associated intestinal injury through CHIP-dependent anti-inflammation and anti-oxidative effect.

Geranylgeranylacetone mitigates sepsis-associated intestinal injury through CHIP-dependent anti-inflammation and anti-oxidative effect.

Journal: International immunopharmacology

Published: April 10, 2024

YL-109 attenuates sepsis-associated multiple organ injury through inhibiting the ERK/AP-1 axis and pyroptosis by upregulating CHIP.

YL-109 attenuates sepsis-associated multiple organ injury through inhibiting the ERK/AP-1 axis and pyroptosis by upregulating CHIP.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 07, 2024

A novel function of claudin-5 in maintaining the structural integrity of the heart and its implications in cardiac pathology.

A novel function of claudin-5 in maintaining the structural integrity of the heart and its implications in cardiac pathology.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: February 07, 2024

Effectiveness evaluation of flipped classroom in emergency medicine online teaching for medical undergraduates.

Effectiveness evaluation of flipped classroom in emergency medicine online teaching for medical undergraduates.

Journal: Medical teacher

Published: November 01, 2023

α 2 -ADRENORECEPTOR ANTAGONIST AMELIORATES SEPSIS-ASSOCIATED PULMONARY FIBROSIS BY SUPPRESSING NOREPINEPHRINE-MEDIATED FIBROBLAST DIFFERENTIATION VIA INHIBITING PKC ACTIVATION.

α 2 -ADRENORECEPTOR ANTAGONIST AMELIORATES SEPSIS-ASSOCIATED PULMONARY FIBROSIS BY SUPPRESSING NOREPINEPHRINE-MEDIATED FIBROBLAST DIFFERENTIATION VIA INHIBITING PKC ACTIVATION.

Journal: Shock (Augusta, Ga.)

Published: October 25, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026